SCHRODER INVESTMENT MANAGEMENT GROUP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$26,000
-72.3%
589
-64.5%
0.00%
Q4 2020$94,000
+118.6%
1,658
+75.1%
0.00%
Q3 2020$43,000
-42.7%
947
-25.6%
0.00%
Q2 2020$75,000
+5.6%
1,272
-8.6%
0.00%
Q1 2020$71,000
-93.6%
1,392
-92.5%
0.00%
-100.0%
Q3 2019$1,101,000
+18.4%
18,647
+62.7%
0.00%0.0%
Q1 2019$930,000
+43.5%
11,460
-4.4%
0.00%
+100.0%
Q4 2018$648,000
-10.7%
11,984
-14.9%
0.00%0.0%
Q3 2018$726,000
+172.9%
14,080
+179.0%
0.00%
Q3 2017$266,000
-33.7%
5,047
-34.9%
0.00%
-100.0%
Q2 2017$401,0007,7490.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders